Zhitong Financial APP News, Changmao Bio (00954) released its results for the six months ended June 30, 2023, with income of 297 million yuan (RMB, the same below), down 23% from the same period last year; profit attributable to shareholders was 4.157 million yuan, down 90% from the same period last year; and basic profit per share was 0.008 yuan.
The main factors affecting the decline in the group's performance in the first half of 2023 are the decline in the unit price of the group's main products in the first half of the year, and the decrease in export sales due to the decline in overseas demand. And the Dalian plant only started operation in the fourth quarter of 2022, and its production and sales are under adjustment. Due to the periodic decline in product prices and trial production, the production capacity and cost of the Dalian factory in the first half of the year did not meet the desired expectations, which has a negative impact on the overall gross profit margin of the group.